Ionis Pharmaceuticals stock price target raised to $55 from $47 at SVB Leerink

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Ionis Pharmaceuticals outlines CEO succession plan

Ionis Pharmaceuticals Inc. said late Thursday that Brett Monia will succeed Stanley Crooke as chief executive in a year. The drug development company said Monia, who is the current chief operating officer, will become CEO in January 2020, and Crooke will become executive chairman of Ionis’s board. Shares of Ionis, which were flat after hours, had closed down 2.1% at $49.78 in regular trading Thursday.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply